| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/27/1997 | EP0791052A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 08/27/1997 | EP0791009A1 Modified neuropeptide y receptors |
| 08/27/1997 | EP0790999A1 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments |
| 08/27/1997 | EP0790996A1 Pyridazinoquinoline compounds |
| 08/27/1997 | EP0790995A1 A method of treating urinary bladder dysfunctions |
| 08/27/1997 | EP0790994A1 Heterocycle substituted propenoic acid derivatives as nmda antagonists |
| 08/27/1997 | EP0790826A1 Dihydropyrimidines and uses thereof |
| 08/27/1997 | EP0679152B1 Anti-androgenic cyclo and bicyclo alkenes |
| 08/27/1997 | EP0647231B1 N-substituted 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents, etc. |
| 08/27/1997 | EP0592438B1 Indole derivatives |
| 08/27/1997 | EP0495781B1 Radiation synovectomy compositions |
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/27/1997 | CN1158128A Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation method and compositions |
| 08/27/1997 | CN1158085A Composition alleviating pain, containing a non-napcotic and an analgesia enhancer |
| 08/27/1997 | CN1157852A Fermentation technology of Xylaria nigripes |
| 08/27/1997 | CN1157822A Pharmaceutical compounds |
| 08/27/1997 | CN1157821A Process for preparation of tetrazole derivatives |
| 08/27/1997 | CN1157815A 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients |
| 08/26/1997 | US5661183 Prevention or treatment of neurodegeneration |
| 08/26/1997 | US5661173 Administering an enzyme inhibitor treating diabetes |
| 08/26/1997 | US5661172 Administering a benzofuranyl imidazole compound for improving memory functions |
| 08/26/1997 | US5661169 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and the pharmaceutical compositions containing them |
| 08/26/1997 | US5661168 Hypoglycemic agents |
| 08/26/1997 | US5661167 Memory enhancement, preventing or slowing the affect of amnesia or memory deficits |
| 08/26/1997 | US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists |
| 08/26/1997 | US5661157 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
| 08/26/1997 | US5661129 Organic nitrates containing a disulfide group as cardiovascular agents |
| 08/26/1997 | US5661032 Controller of transcription of marker gene |
| 08/26/1997 | US5661007 Culturing; recovering; purification; administering to induce bone and/or cartilage formation |
| 08/26/1997 | US5660860 Acyclovir in water dispersible tablet; herpes virus treatment |
| 08/26/1997 | US5660859 Gelation of low-molecular weight polymer in water using calcium acetate at room temperature; drug capsules; dental products; cosmetics; cariers |
| 08/26/1997 | US5660837 Preparing pharmaceutical formulation in form of oil-in-water emulsion |
| 08/26/1997 | US5660835 Method of treating adenosine depletion |
| 08/26/1997 | CA2069931C Muscarinic receptor antagonists |
| 08/26/1997 | CA1339365C Oligopeptides and intermediates and processes for their manufacture |
| 08/21/1997 | WO1997030178A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | WO1997030072A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 08/21/1997 | WO1997030056A1 Spiro-ketal derivatives and their use as therapeutic agents |
| 08/21/1997 | WO1997030055A1 Spiro-ketal derivatives and their use as therapeutic agents |
| 08/21/1997 | WO1997030048A1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 08/21/1997 | WO1997030046A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 08/21/1997 | WO1997030045A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 08/21/1997 | WO1997030042A1 Polyester cyclic compounds, their complexes and bonded bodies |
| 08/21/1997 | WO1997029774A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 08/21/1997 | WO1997029764A1 Brain activators |
| 08/21/1997 | WO1997029748A1 Substituted biphenyl isoxazole sulfonamides |
| 08/21/1997 | WO1997029746A1 Inhibition of protein glycation and prevention of vasculopathy |
| 08/21/1997 | WO1997029745A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | WO1997029740A1 Multiple sclerosis treatment |
| 08/21/1997 | WO1997029739A2 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | DE19612504A1 Muscarine agonist and peripherally active anti-muscarine composition |
| 08/21/1997 | CA2634973A1 Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 08/21/1997 | CA2412954A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 08/21/1997 | CA2246362A1 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | CA2246336A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 08/21/1997 | CA2245684A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 08/21/1997 | CA2240043A1 Substituted biphenyl isoxazole sulfonamides |
| 08/21/1997 | CA2230639A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | CA2197847A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of borna disease virus, nucleic acid fragments coding therefor and their use for diagnostic and immunization purposes |
| 08/20/1997 | EP0790254A1 Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them |
| 08/20/1997 | EP0790250A2 Inhibitors of biogenic amine transporters |
| 08/20/1997 | EP0790248A1 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists |
| 08/20/1997 | EP0790239A1 Novel 4-phenyl-2-(piperazinyl/perhydrodiazepinyl/aminoalkyl)carbonylmethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid derivatives as bradykinin receptor antagonists |
| 08/20/1997 | EP0790237A1 Bicyclolactam compounds, use of the same and intermediate in the production of the same |
| 08/20/1997 | EP0790236A1 Pro-drugs of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one |
| 08/20/1997 | EP0790059A1 Means for treating auto-immune diseases and method of treatment |
| 08/20/1997 | EP0789776A1 Nucleic acid transfer system |
| 08/20/1997 | EP0789757A1 Transgenic organisms and their uses |
| 08/20/1997 | EP0789713A1 Antibodies |
| 08/20/1997 | EP0789709A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 08/20/1997 | EP0789702A1 Substituted tetracyclic oxazepine and thiazepine derivatives with 5-ht2 receptor affinity |
| 08/20/1997 | EP0789699A1 SPIRO HETEROCYCLE-IMIDAZO(1,2-a]INDENO(1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 08/20/1997 | EP0789575A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/20/1997 | EP0789571A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase |
| 08/20/1997 | EP0789567A1 A method for treating vascular headaches |
| 08/20/1997 | EP0629197B1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 08/20/1997 | EP0579833B1 Ethanolamine derivatives with anti-pollakiuria activity |
| 08/20/1997 | EP0502031B1 N-substituted azaheterocyclic carboxylic acids and a pharmaceutical composition |
| 08/20/1997 | CN1157620A Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 08/20/1997 | CN1157615A Heterocyclic tachykinin receptor antagonists |
| 08/20/1997 | CN1157613A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/20/1997 | CN1157609A Heterocyclic derivative and medicine |
| 08/20/1997 | CN1157286A N,N-dimethyl-1-t-butoxycarbonyl-4-phenylpiperidine-4-carboxamide |
| 08/19/1997 | USRE35593 Therapy for dermentia |
| 08/19/1997 | US5659033 Psychological disorders |
| 08/19/1997 | US5658949 Inhibition of tumor necrosis factor by retinoic acid |
| 08/19/1997 | US5658934 Aryl-substituted alkoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid esters |
| 08/19/1997 | US5658932 Azacyclic compounds; cognitive function stimulants; alzheimer's disease |
| 08/19/1997 | US5658925 Aminobenzoic acid derivatives |
| 08/19/1997 | US5658921 Potent sigma receptor ligands; water solubility; symmetry |
| 08/19/1997 | US5658916 Drug active on the central nervous system, a process for the preparation thereof and pharmaceutical compositions containing it |
| 08/19/1997 | US5658911 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 08/19/1997 | US5658910 Nicotinic acid esters |
| 08/19/1997 | US5658909 Inhibition of abnormally phosphorylated paired helical filament epitope formation |
| 08/19/1997 | US5658908 Opioid diarylmethylpiperazines and piperdines |
| 08/19/1997 | US5658905 Use of triazine compounds as anxiolytics |
| 08/19/1997 | US5658903 Cytokine inhibitors |
| 08/19/1997 | US5658900 Application of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and parkinsonian syndromes |
| 08/19/1997 | US5658899 Acid addition salts of 2, 3, 4, 5-tetrahydro-1H-3-benzazepine compounds |